html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8" />
<title>Opportunity Analysis Report</title>
<meta name="viewport" content="width=device-width,initial-scale=1" />
<style>
body{font-family:Arial,sans-serif;line-height:1.6;color:#333;max-width:1200px;margin:0 auto;padding:20px;background:#f5f5f5}
h1{color:#2c3e50;border-bottom:3px solid #2c3e50;padding-bottom:10px;margin-top:0}
h2{color:#34495e;margin-top:30px}
.summary,.metrics,.toc{background:#fff;padding:20px;border-radius:8px;margin-bottom:20px;box-shadow:0 2px 4px rgba(0,0,0,0.1)}
.metrics-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:20px;margin-top:15px}
.metric-box{background:#f8f9fa;padding:15px;border-radius:5px;border-left:4px solid #2c3e50}
.metric-label{font-size:.9em;color:#666;margin-bottom:5px}
.metric-value{font-size:1.5em;font-weight:bold;color:#2c3e50}
.toc ul{columns:2;column-gap:30px;margin:0;padding-left:20px}
.toc li{margin-bottom:8px;break-inside:avoid}
.toc a{color:#2c3e50;text-decoration:none}
.toc a:hover{text-decoration:underline}
table{background:#fff;box-shadow:0 2px 4px rgba(0,0,0,0.1);border-radius:8px;overflow:hidden;border-collapse:collapse;width:100%;margin-bottom:30px}
td{border:1px solid #ddd;padding:10px;vertical-align:top}
.th{background:#f0f0f0;font-weight:bold;width:25%}
.head{background:#2c3e50;color:#fff;font-weight:bold;padding:12px}
table.inner{width:100%;border-collapse:collapse;margin-top:8px}
table.inner td{border:1px solid #eee;padding:8px}
details > summary::-webkit-details-marker{display:none}
details[open] > summary{margin-bottom:8px}
@media print{.toc{page-break-after:always} body{background:#fff}}
</style>
</head>
<body>
<h1>Opportunity Analysis Report</h1>

<div class="summary">
<p><strong>Report Generated:</strong> 9/22/2025 at 8:41:15 PM</p>
<p><strong>Total Opportunities Analyzed:</strong> 8</p>
</div>

<div class="metrics">
<h2>Executive Summary</h2>
<div class="metrics-grid">
<div class="metric-box">
<div class="metric-label">Total Pipeline Value</div>
<div class="metric-value">$5,535,523</div>
</div>
<div class="metric-box">
<div class="metric-label">Average KF Score</div>
<div class="metric-value">65</div>
</div>
<div class="metric-box">
<div class="metric-label">Total Opportunities</div>
<div class="metric-value">8</div>
</div>
</div>
<div style="margin-top:20px;">
<p><strong>Stage Distribution:</strong> 5. Proposal/Price Quote: 3 | 4. Scoping: 2 | 7. Final Contract Execution: 2 | Contract Red-line Received: 1</p>
<p><strong>Forecast Categories:</strong> Best Case: 6 | Commit: 1 | N/A: 1</p>
</div>
</div>

<div class="toc">
<h2>Table of Contents</h2>
<p style="color:#666;font-size:.9em;">Opportunities sorted by ACV (highest to lowest)</p>
<ul><li><a href="#opp-0">Compassus - Platform Sale Expansion - $2,200,000</a></li><li><a href="#opp-1">Allegiance Healthcare - $2,000,000</a></li><li><a href="#opp-2">Baystate - PK Autonomous Coding co-dev - $1,000,000</a></li><li><a href="#opp-3">Beebe Medical Center - Strongline - Duress - New Business - $135,000</a></li><li><a href="#opp-4">Doctors RCM - $93,123</a></li><li><a href="#opp-5">Chesapeake Regional MC - Pilot conversion - $71,400</a></li><li><a href="#opp-6">Beth Israel Bayridge - Duress - Expansion - $20,000</a></li><li><a href="#opp-7">Beth Israel Anna Jaques - Strongline - Expansion - $16,000</a></li></ul>
</div>

<h2>Detailed Opportunity Analysis</h2>

<table id="opp-0">
<tr><td class="head" colspan="2">Opportunity #1</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Compassus - Platform Sale Expansion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Eric Valentin</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$2,200,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#28a745;">100</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Compassus is pursuing Platform Sale Expansion with a platform-wide ACV of $2,200,000 and a perfect KF score of 100. The lack of Bluesheet data suggests a concentrated engagement with key stakeholders within Compassus but without a formal Bluesheet attachment. The forecast is strong, with significant momentum toward a platform-wide deployment. The Next Step indicates ongoing progression toward final acceptance, with a timeline that could slip into month-end. The opportunity benefits from deep cross-functional sponsorship and a proven approach to ROI, but will require disciplined governance to maintain momentum to contract.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">No explicit red flags; reliance on final acceptance and governance</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Ensure cross-functional approvals are in place; lock down final pricing and governance plans; keep executive sponsor engaged.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>6.26 - Acceptance will go down likely to the final month</li><li>(Proposed) Finalize platform-level governance and approvals</li><li>(Proposed) Align with legal for final contract terms</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Compassus - Platform Sale Expansion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Eric Valentin</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$2,200,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>100</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Compassus is pursuing Platform Sale Expansion with a platform-wide ACV of $2,200,000 and a perfect KF score of 100. The lack of Bluesheet data suggests a concentrated engagement with key stakeholders within Compassus but without a formal Bluesheet attachment. The forecast is strong, with significant momentum toward a platform-wide deployment. The Next Step indicates ongoing progression toward final acceptance, with a timeline that could slip into month-end. The opportunity benefits from deep cross-functional sponsorship and a proven approach to ROI, but will require disciplined governance to maintain momentum to contract.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>No explicit red flags; reliance on final acceptance and governance</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Ensure cross-functional approvals are in place; lock down final pricing and governance plans; keep executive sponsor engaged.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>6.26 - Acceptance will go down likely to the final month</li><li>(Proposed) Finalize platform-level governance and approvals</li><li>(Proposed) Align with legal for final contract terms</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-1">
<tr><td class="head" colspan="2">Opportunity #2</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Allegiance Healthcare</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Mick Majewski</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$2,000,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">75</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Allegiance Healthcare is in Scoping with a Best Case forecast and a $2,000,000 ACV. The Blue Sheet data shows broad engagement across investor influences and a strong KF score (75), indicating a well-corroborated business case. There are no explicit red flags at this moment, but successful conversion will hinge on onsite scheduling and timely budget alignment. The Next Step is an onsite visit scheduled in Buffalo, with additional steps to align budget and sponsorship. Overall, momentum is solid across multiple stakeholders, suggesting a credible path to a contracted engagement if scheduling and funding align.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Upcoming onsite scheduling and budget alignment risk</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Coordinate with economic buying influences to lock in the onsite date and secure budget sign-off; engage executive sponsor to maintain momentum.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.10 - scheduling onsite in buffalo</li><li>(Proposed) Confirm budget and procurement timelines</li><li>(Proposed) Align executive sponsor</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Allegiance Healthcare</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Mick Majewski</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$2,000,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>75</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Allegiance Healthcare is in Scoping with a Best Case forecast and a $2,000,000 ACV. The Blue Sheet data shows broad engagement across investor influences and a strong KF score (75), indicating a well-corroborated business case. There are no explicit red flags at this moment, but successful conversion will hinge on onsite scheduling and timely budget alignment. The Next Step is an onsite visit scheduled in Buffalo, with additional steps to align budget and sponsorship. Overall, momentum is solid across multiple stakeholders, suggesting a credible path to a contracted engagement if scheduling and funding align.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Upcoming onsite scheduling and budget alignment risk</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Coordinate with economic buying influences to lock in the onsite date and secure budget sign-off; engage executive sponsor to maintain momentum.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.10 - scheduling onsite in buffalo</li><li>(Proposed) Confirm budget and procurement timelines</li><li>(Proposed) Align executive sponsor</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-2">
<tr><td class="head" colspan="2">Opportunity #3</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Baystate - PK Autonomous Coding co-dev</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Amy Sullivan</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$1,000,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">70</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Baystate Medical Center is in the Proposal/Price Quote stage with a $1,000,000 ACV and a Best Case forecast. The KF score of 70 and Bluesheet data indicate meaningful cross-functional engagement and a likely business case, with no major red flags. The primary risk relates to budget approval and the timing of the amendment needed to proceed with the upgrade and resource alignment. The Next Step shows progression to amendment contingent on budget approval, with ongoing stakeholder engagement. The deal exhibits solid momentum but requires timely budget sign-off to advance into contract/implementation.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Budget approval and amendment timing risk</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Secure budget authorization promptly and finalize amendment scope; align AC resources and stakeholders for quick sign-off.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.2 they have slotted in the upgrade and AC resources, assuming budget approval, moving to next phase which is amendment.</li><li>(Proposed) Confirm budget approval and amendment plan</li><li>(Proposed) Lock in amendment timeline and legal review</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Baystate - PK Autonomous Coding co-dev</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Amy Sullivan</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$1,000,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>70</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Baystate Medical Center is in the Proposal/Price Quote stage with a $1,000,000 ACV and a Best Case forecast. The KF score of 70 and Bluesheet data indicate meaningful cross-functional engagement and a likely business case, with no major red flags. The primary risk relates to budget approval and the timing of the amendment needed to proceed with the upgrade and resource alignment. The Next Step shows progression to amendment contingent on budget approval, with ongoing stakeholder engagement. The deal exhibits solid momentum but requires timely budget sign-off to advance into contract/implementation.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Budget approval and amendment timing risk</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Secure budget authorization promptly and finalize amendment scope; align AC resources and stakeholders for quick sign-off.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.2 they have slotted in the upgrade and AC resources, assuming budget approval, moving to next phase which is amendment.</li><li>(Proposed) Confirm budget approval and amendment plan</li><li>(Proposed) Lock in amendment timeline and legal review</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-3">
<tr><td class="head" colspan="2">Opportunity #4</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Beebe Medical Center - Strongline - Duress - New Business</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$135,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#dc3545;">37</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Beebe Medical Center is in Proposal/Price Quote for the Strongline Duress deployment with a $135,000 ACV. The Bluesheet data is present, reflecting executive-level attention and a plan to fund if needed, while the EPIC project timing could impact go-live. The limited Blue Sheet data places a premium on budget alignment and sponsor support to drive the proposal through final approval. The Next Step indicates a budget update this week and potential connections with key stakeholders to accelerate scoping. The opportunity shows traction but hinges on timely budget decisions and Epic-related dependencies.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Budget approval timing and EPIC project delay</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Coordinate with finance and the CEO sponsor to secure budget; align EPIC integration timeline; accelerate approvals where possible.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - haven't received update yet on budget. Will see if I can connect with RK on 9/8</li><li>(Proposed) Coordinate budget updates with executive sponsor</li><li>(Proposed) Align EPIC integration plan</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Beebe Medical Center - Strongline - Duress - New Business</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$135,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>37</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Beebe Medical Center is in Proposal/Price Quote for the Strongline Duress deployment with a $135,000 ACV. The Bluesheet data is present, reflecting executive-level attention and a plan to fund if needed, while the EPIC project timing could impact go-live. The limited Blue Sheet data places a premium on budget alignment and sponsor support to drive the proposal through final approval. The Next Step indicates a budget update this week and potential connections with key stakeholders to accelerate scoping. The opportunity shows traction but hinges on timely budget decisions and Epic-related dependencies.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Budget approval timing and EPIC project delay</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Coordinate with finance and the CEO sponsor to secure budget; align EPIC integration timeline; accelerate approvals where possible.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - haven't received update yet on budget. Will see if I can connect with RK on 9/8</li><li>(Proposed) Coordinate budget updates with executive sponsor</li><li>(Proposed) Align EPIC integration plan</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-4">
<tr><td class="head" colspan="2">Opportunity #5</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Doctors RCM</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>David Swanson</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$93,123</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#dc3545;">49</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Doctors RCM is in Scoping with a Best Case forecast and a $93,123 ACV. Bluesheet data is present, signaling active engagement with a CoE and partner involvement in scoping. The data shows some reliance on budget timing and multiple stakeholder input, though red flags are minimal. The Next Step indicates ongoing scoping discussions, consistent with a path toward a defined ROI and customer-specific success criteria. The opportunity demonstrates potential value but hinges on timely alignment of partners and procurement approvals.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Budget alignment and partner involvement</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Engage partners early, align budget timeline, and secure sponsor alignment to move toward scoping completion.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/17 getting partner back involved to have Dr. Diggiss direct Sam for scoping meeting.</li><li>(Proposed) Confirm partner roles and responsibilities for scoping</li><li>(Proposed) Validate budget and procurement path</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Doctors RCM</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>David Swanson</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$93,123</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>49</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Doctors RCM is in Scoping with a Best Case forecast and a $93,123 ACV. Bluesheet data is present, signaling active engagement with a CoE and partner involvement in scoping. The data shows some reliance on budget timing and multiple stakeholder input, though red flags are minimal. The Next Step indicates ongoing scoping discussions, consistent with a path toward a defined ROI and customer-specific success criteria. The opportunity demonstrates potential value but hinges on timely alignment of partners and procurement approvals.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Budget alignment and partner involvement</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Engage partners early, align budget timeline, and secure sponsor alignment to move toward scoping completion.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/17 getting partner back involved to have Dr. Diggiss direct Sam for scoping meeting.</li><li>(Proposed) Confirm partner roles and responsibilities for scoping</li><li>(Proposed) Validate budget and procurement path</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-5">
<tr><td class="head" colspan="2">Opportunity #6</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Chesapeake Regional MC - Pilot conversion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Marc DeLaurentis</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>Contract Red-line Received</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Commit</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$71,400</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/3/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#28a745;">82</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Chesapeake Regional MC is in Contract with a redline received for a Pilot conversion. The ACV is $71,400 and the KF score is strong at 82, with Bluesheet data present (BS-00013). The engagement shows a clear path to finalizing the CORL/SOW, with internal reviews and sponsor involvement expected to finalize the commitment. There are no explicit red flags in the data, but success hinges on completing redlines and obtaining cross-functional sign-off. Next steps emphasize internal alignment and legal review to close the contract.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Internal alignment to CORL SOW and CORL feedback</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Finalize redlines promptly; engage with internal sponsors to secure timely approval; align with CORL objectives.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>Virginia connecting internally and providing feedback on CORL. SOW sent for review. These should be last steps</li><li>(Proposed) Finalize CORL/SOW and obtain sign-off</li><li>(Proposed) Align legal and procurement timelines</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Chesapeake Regional MC - Pilot conversion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Marc DeLaurentis</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>Contract Red-line Received</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Commit</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$71,400</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/3/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>82</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Chesapeake Regional MC is in Contract with a redline received for a Pilot conversion. The ACV is $71,400 and the KF score is strong at 82, with Bluesheet data present (BS-00013). The engagement shows a clear path to finalizing the CORL/SOW, with internal reviews and sponsor involvement expected to finalize the commitment. There are no explicit red flags in the data, but success hinges on completing redlines and obtaining cross-functional sign-off. Next steps emphasize internal alignment and legal review to close the contract.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Internal alignment to CORL SOW and CORL feedback</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Finalize redlines promptly; engage with internal sponsors to secure timely approval; align with CORL objectives.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>Virginia connecting internally and providing feedback on CORL. SOW sent for review. These should be last steps</li><li>(Proposed) Finalize CORL/SOW and obtain sign-off</li><li>(Proposed) Align legal and procurement timelines</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-6">
<tr><td class="head" colspan="2">Opportunity #7</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Beth Israel Bayridge - Duress - Expansion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td></td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$20,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/30/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#dc3545;">40</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>BayRidge Hospital is in Final Contract Execution for a Duress expansion with an ACV of $20,000. The opportunity shows engagement but lacks Bluesheet data and a forecast, indicating a narrower but meaningful expansion. The absence of red flags suggests that contract execution hinges on timely signature and procurement clearance. The Next Step indicates ongoing signature discussions, while the risk remains around contract closure timing. Overall, progress exists, but closing is dependent on timely legal and administrative approvals.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Signature and procurement clearance timing</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Streamline legal review and align procurement priorities to accelerate signature.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Coordinate with legal for fast-tracked signature</li><li>(Proposed) Confirm procurement readiness and timeline</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Beth Israel Bayridge - Duress - Expansion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td></td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$20,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/30/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>40</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>BayRidge Hospital is in Final Contract Execution for a Duress expansion with an ACV of $20,000. The opportunity shows engagement but lacks Bluesheet data and a forecast, indicating a narrower but meaningful expansion. The absence of red flags suggests that contract execution hinges on timely signature and procurement clearance. The Next Step indicates ongoing signature discussions, while the risk remains around contract closure timing. Overall, progress exists, but closing is dependent on timely legal and administrative approvals.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Signature and procurement clearance timing</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Streamline legal review and align procurement priorities to accelerate signature.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Coordinate with legal for fast-tracked signature</li><li>(Proposed) Confirm procurement readiness and timeline</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-7">
<tr><td class="head" colspan="2">Opportunity #8</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Beth Israel Anna Jaques - Strongline - Expansion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$16,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/19/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">66</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Anna Jaques Hospital is in Final Contract Execution for Strongline expansion with a modest ACV of $16,000. The KF score of 66 and lack of Bluesheet data indicate active engagement with several influencers, including a notable investment/advisor influence. The primary risk is tied to signature timing; while the deal has demonstrated momentum, legal and procurement lead times could slow the closing. The Next Step shows ongoing signature activity, with a plan to move to closure once approvals are obtained. Overall, the deal reflects strategic sponsorship and a clear expansion path, contingent on timely signature.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Signature delay</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Engage legal early and parallelize reviews; confirm finance sign-off and expedite contracting steps.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Coordinate signature with legal and procurement</li><li>(Proposed) Confirm finance sign-off and next steps for contract finalization</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Beth Israel Anna Jaques - Strongline - Expansion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$16,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/19/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>66</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Anna Jaques Hospital is in Final Contract Execution for Strongline expansion with a modest ACV of $16,000. The KF score of 66 and lack of Bluesheet data indicate active engagement with several influencers, including a notable investment/advisor influence. The primary risk is tied to signature timing; while the deal has demonstrated momentum, legal and procurement lead times could slow the closing. The Next Step shows ongoing signature activity, with a plan to move to closure once approvals are obtained. Overall, the deal reflects strategic sponsorship and a clear expansion path, contingent on timely signature.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Signature delay</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Engage legal early and parallelize reviews; confirm finance sign-off and expedite contracting steps.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Coordinate signature with legal and procurement</li><li>(Proposed) Confirm finance sign-off and next steps for contract finalization</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>
</body>
</html>
